Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.30 |
| ▸ | F13A1 | P00488 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | FASN | P49327 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6199757 | 1.00 | PPARA (0.31) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL4929461 | 1.00 | PPARA (0.31) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL6199761 | 1.00 | PPARA (0.31) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL6202636 | 0.92 | ALDH1A1 (0.38) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL6202638 | 0.92 | ALDH1A1 (0.38) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL16103147 | 0.88 | ALOX12 (0.33) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL16103148 | 0.88 | ALOX12 (0.33) | PPARAALDH1A1MAPTFFAR1CYP19A1 | |
| SCHEMBL28427560 | 0.87 | — | — | |
| SCHEMBL22611958 | 0.87 | LSS (0.33) | PPARAPPARG | |
| SCHEMBL22611959 | 0.87 | LSS (0.33) | PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1268457-A4 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORP (US) | 2005-07-20 | — | — | EP | claimed |
| JP-2003529643-A | — | — | 2003-10-07 | — | — | JP | claimed |
| EP-1268457-A1 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORPORATION (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001074798-A1 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORPORATION (US) | 2001-10-11 | — | — | WO | claimed |
| EP-3512891-A1 | FARNESENE-BASED MACROMONOMERS AND METHODS OF MAKING AND USING THE SAME | Fina Technology, Inc. (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018052709-A1 | FARNESENE-BASED MACROMONOMERS AND METHODS OF MAKING AND USING THE SAME | FINA TECHNOLOGY, INC. (US) | 2018-03-22 | — | — | WO | disclosed |
| EP-3071782-A1 | MODIFIED HYDROCARBON RESINS AS FLUID LOSS ADDITIVES | Georgia-Pacific Chemicals LLC (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2015077215-A1 | MODIFIED HYDROCARBON RESINS AS FLUID LOSS ADDITIVES | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2015-05-28 | — | — | WO | disclosed |
| US-20080160116-A1 | Compositions and Methods Comprising Zingiber Species | HERBALSCIENCE SINGAPORE PTE. LTD (SG) | 2008-07-03 | — | — | US | disclosed |
| US-20070292540-A1 | Extracts and Methods Comprising Cinnamon Species | HERBALSCIENCE SINGAPORE PTE. LTD. (SG) | 2007-12-20 | — | — | US | disclosed |
| EP-1268457-A4 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORP (US) | 2005-07-20 | — | — | EP | disclosed |
| EP-1268457-A1 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORPORATION (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074798-A1 | REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT | LOCTITE CORPORATION (US) | 2001-10-11 | — | — | WO | disclosed |
| US-4480123-A | Preparation of diacyloxyalkadienes | BASF AKTIENGESELLSCHAFT (DE) | 1984-10-30 | — | — | US | disclosed |
| EP-0058236-B1 | DIACYLOXYALKADIENES AND THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1984-04-25 | — | — | EP | disclosed |
| EP-0058236-A1 | Diacyloxyalkadienes and their preparation | BASF Aktiengesellschaft (DE) | 1982-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080160116-A1 | Compositions and Methods Comprising Zingiber Species | AGL, SQLE, RBPJ | PPARA 473/4885ALDH1A1 1755/4885MAPT 2135/4885 |
| US-20070292540-A1 | Extracts and Methods Comprising Cinnamon Species | MT-CO2, CA7, CES2 | PPARA 1933/4885ALDH1A1 1820/4885MAPT 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.